Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Respiratory chain complex I is a mitochondrial tumor suppressor of oncocytic tumors.

Zimmermann FA, Mayr JA, Feichtinger R, Neureiter D, Lechner R, Koegler C, Ratschek M, Rusmir H, Sargsyan K, Sperl W, Kofler B.

Front Biosci (Elite Ed). 2011 Jan 1;3:315-25. Review.

PMID:
21196312
2.

Mitochondrial complex I is deficient in renal oncocytomas.

Simonnet H, Demont J, Pfeiffer K, Guenaneche L, Bouvier R, Brandt U, Schagger H, Godinot C.

Carcinogenesis. 2003 Sep;24(9):1461-6. Epub 2003 Jul 4.

3.

Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III.

Bonora E, Porcelli AM, Gasparre G, Biondi A, Ghelli A, Carelli V, Baracca A, Tallini G, Martinuzzi A, Lenaz G, Rugolo M, Romeo G.

Cancer Res. 2006 Jun 15;66(12):6087-96.

4.

Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma.

Gasparre G, Hervouet E, de Laplanche E, Demont J, Pennisi LF, Colombel M, Mège-Lechevallier F, Scoazec JY, Bonora E, Smeets R, Smeitink J, Lazar V, Lespinasse J, Giraud S, Godinot C, Romeo G, Simonnet H.

Hum Mol Genet. 2008 Apr 1;17(7):986-95. Epub 2007 Dec 21.

5.

Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma.

Mayr JA, Meierhofer D, Zimmermann F, Feichtinger R, Kögler C, Ratschek M, Schmeller N, Sperl W, Kofler B.

Clin Cancer Res. 2008 Apr 15;14(8):2270-5. doi: 10.1158/1078-0432.CCR-07-4131.

6.

Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases.

Petersson F, Gatalica Z, Grossmann P, Perez Montiel MD, Alvarado Cabrero I, Bulimbasic S, Swatek A, Straka L, Tichy T, Hora M, Kuroda N, Legendre B, Michal M, Hes O.

Virchows Arch. 2010 Apr;456(4):355-65. doi: 10.1007/s00428-010-0898-4. Epub 2010 Mar 19.

PMID:
20300772
7.

Adrenocortical oncocytic tumors: report of 10 cases and review of the literature.

Bisceglia M, Ludovico O, Di Mattia A, Ben-Dor D, Sandbank J, Pasquinelli G, Lau SK, Weiss LM.

Int J Surg Pathol. 2004 Jul;12(3):231-43.

PMID:
15306935
8.

Review of renal oncocytoma with focus on clinical and pathobiological aspects.

Kuroda N, Toi M, Hiroi M, Shuin T, Enzan H.

Histol Histopathol. 2003 Jul;18(3):935-42. Review.

PMID:
12792905
9.

PGC-1-related coactivator and targets are upregulated in thyroid oncocytoma.

Savagner F, Mirebeau D, Jacques C, Guyetant S, Morgan C, Franc B, Reynier P, Malthièry Y.

Biochem Biophys Res Commun. 2003 Oct 24;310(3):779-84.

PMID:
14550271
10.

Coordinate expression of nuclear and mitochondrial genes involved in energy production in carcinoma and oncocytoma.

Heddi A, Faure-Vigny H, Wallace DC, Stepien G.

Biochim Biophys Acta. 1996 Aug 23;1316(3):203-9.

PMID:
8781539
11.

Restoration of mitochondrial function in cells with complex I deficiency.

Bai Y, Park JS, Deng JH, Li Y, Hu P.

Ann N Y Acad Sci. 2005 May;1042:25-35.

PMID:
15965042
12.

Learning from oncocytic tumors: Why choose inefficient mitochondria?

Gasparre G, Romeo G, Rugolo M, Porcelli AM.

Biochim Biophys Acta. 2011 Jun;1807(6):633-42. doi: 10.1016/j.bbabio.2010.08.006. Epub 2010 Aug 21. Review.

13.

Proteome and cytoskeleton responses in osteosarcoma cells with reduced OXPHOS activity.

Annunen-Rasila J, Ohlmeier S, Tuokko H, Veijola J, Majamaa K.

Proteomics. 2007 Jun;7(13):2189-200.

PMID:
17533645
15.

Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma.

Simonnet H, Alazard N, Pfeiffer K, Gallou C, Béroud C, Demont J, Bouvier R, Schägger H, Godinot C.

Carcinogenesis. 2002 May;23(5):759-68.

16.

A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors.

Evangelisti C, de Biase D, Kurelac I, Ceccarelli C, Prokisch H, Meitinger T, Caria P, Vanni R, Romeo G, Tallini G, Gasparre G, Bonora E.

BMC Cancer. 2015 Mar 21;15:157. doi: 10.1186/s12885-015-1122-3.

17.

Renal oncocytoma with and without intravascular extension into the branches of renal vein have the same morphological, immunohistochemical and genetic features.

Hes O, Michal M, Síma R, Vanecek T, Brunelli M, Martignoni G, Kuroda N, Cabrero IA, Perez-Montiel D, Hora M, Urge T, Dvorák M, Jarosová M, Yang X.

Virchows Arch. 2008 Mar;452(3):285-93. doi: 10.1007/s00428-007-0564-7.

PMID:
18196270
18.

Transcriptional profiling reveals coordinated up-regulation of oxidative metabolism genes in thyroid oncocytic tumors.

Baris O, Savagner F, Nasser V, Loriod B, Granjeaud S, Guyetant S, Franc B, Rodien P, Rohmer V, Bertucci F, Birnbaum D, Malthièry Y, Reynier P, Houlgatte R.

J Clin Endocrinol Metab. 2004 Feb;89(2):994-1005.

PMID:
14764826
19.

Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dubé tumors.

Lang M, Vocke CD, Merino MJ, Schmidt LS, Linehan WM.

Mod Pathol. 2015 Nov;28(11):1458-69. doi: 10.1038/modpathol.2015.101. Epub 2015 Oct 2.

20.

Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors.

Gasparre G, Porcelli AM, Bonora E, Pennisi LF, Toller M, Iommarini L, Ghelli A, Moretti M, Betts CM, Martinelli GN, Ceroni AR, Curcio F, Carelli V, Rugolo M, Tallini G, Romeo G.

Proc Natl Acad Sci U S A. 2007 May 22;104(21):9001-6. Epub 2007 May 15.

Items per page

Supplemental Content

Write to the Help Desk